ArticleLipids in health and disease2026
Clinical significance and prognostic value of high-density lipoprotein cholesterol-based markers in very young patients with coronary artery disease: a retrospective study.
Article in Lipids in health and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe increasing prevalence of coronary artery disease (CAD) in young adults necessitates effective early risk assessment tools. Inflammation and dyslipidemia are pivotal in atherogenesis. This study aimed to evaluate the predictive value of high-density lipoprotein cholesterol (HDL-C)-based markers—specifically the neutrophil-to-HDL-C ratio (NHR), the monocyte-to-HDL-C ratio (MHR), and the low-density lipoprotein cholesterol (LDL-C)/HDL-C ratio—for CAD, acute coronary syndrome (ACS), severe coronary stenosis, and clinical prognosis in very young patients.
methodsThis retrospective study included 1,074 patients aged 18–35 years who underwent coronary angiography. Patients were classified into a CAD group (n = 878) and a non-CAD group (n = 196). Lesion severity was assessed using the Gensini score. Multivariable logistic regression was performed to identify predictors of CAD, ACS, and severe coronary stenosis (Gensini score > 40). Receiver operating characteristic (ROC) curves were used to evaluate the predictive values of NHR, MHR, and the LDL-C/HDL-C ratio. Restricted cubic spline (RCS) regression was employed to explore nonlinear relationships. COX regression was used to assess factors associated with major adverse cardiovascular events (MACE).
resultsThe prevalence of CAD and ACS showed a progressive increase across ascending quartiles of NHR, MHR, and the LDL-C/HDL-C ratio (P for trend < 0.05). After multivariable adjustment, MHR remained an independent risk factor for CAD (P < 0.001), whereas NHR and the LDL-C/HDL-C ratio did not. For ACS, both NHR and MHR were independently associated (P < 0.001). ROC analysis showed MHR and the LDL-C/HDL-C ratio predicted CAD, while NHR exhibited superior predictive value for ACS (AUC = 0.953). Both NHR and MHR independently predicted severe coronary stenosis, with no significant nonlinear association observed via RCS analysis. Over a median follow-up of 7.8 years, smoking, higher Gensini score, and the elevated ratio of LDL-C/HDL-C emerged as independent risk factors for MACE (P < 0.05).
conclusionsNHR demonstrates excellent predictive value for ACS and is independently associated with severe coronary stenosis. MHR is an independent risk factor for CAD, while the LDL-C/HDL-C ratio independently predicts long-term MACE. These readily available indices may facilitate early risk stratification and intervention in very young CAD patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.